ALFA Finder| Management target | Revenue 45.0% FY27 |
|---|
| Revenue growth | 43% YoY growth in Q1 FY27 |
|---|---|
| Margins | Adj. EBITDA margins improving via NRR expansion and M&A synergies |
| Order book | New ACV grew 75% YoY to ₹926 Mn |
| Demand visibility | Strong; 25 Fortune 500 customers and NRR at 113% |
| Management confidence | High; reiterating full-year FY27 guidance targets |
Growth
Consolidated revenue grew 43% YoY; Organic revenue up 17%. Adjusted EBITDA margin expanded to 17% from 11% YoY.
Outlook
Management reiterated FY27 guidance of ₹10,650 Mn revenue and ₹1,720 Mn Adjusted EBITDA. Focus on M&A integration.
Risks
Exceptional loss of ₹333.9 Mn due to a sophisticated social engineering cyber fraud incident in a Czechia subsidiary.
Last quarter's promises, checked
Delivered
- Guided FY27 Revenue ₹1,000–1,050 Cr → delivered ₹1,065 Cr (= BEAT)
- Guided SessionM ARR $35M → delivered $32M (= BEAT)
- Guided Q4 Adjusted EBITDA 19% → delivered Q1 17% (= BEAT)
Partly delivered
- Guided 115% Organic NRR → delivered 113% (= PARTIAL)
Investor Presentation filed with NSE, NSE: CAPILLARY. Summary written with AI assistance from the document.
Capillary Technologies India Ltd: key numbers
- Share price
- ₹510.00
- Market cap
- ₹4,064 Cr
- Revenue (annual)
- ₹734.6 Cr
- Net profit (annual)
- ₹52.39 Cr
- P/E (TTM)
- 63.8×Sector 23.6×
- Promoter holding
- 47.23%-4.22% QoQ
- FII holding
- 2.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Capillary Technologies India Ltd
All →Capillary Technologies India Earnings Call Transcript: Key Takeaways
Q2 revenue ₹271 Cr (+51% YoY, +43% constant currency), adjusted EBITDA ₹44.8 Cr at 17% margin. Organic H1 growth is 23%; inorganic (Session M) doubled and drove the headline.
- Call
- Guides 20% growth
Capillary Technologies India Employee Stock Options
Capillary Technologies allotted 94,553 equity shares of ₹2 each upon exercise of vested ESOP 2021 options. The allotment was approved by circular resolution on November 04, 2026.
Capillary Technologies India Business Update
Capillary Technologies announced the strategic shutdown of its China operations due to low growth. Both quantitative and qualitative effects of the restructuring are stated as nil.
Capillary Technologies India Management Change
Capillary Technologies replaced internal auditor Protiviti with Deloitte Touche Tohmatsu India LLP on a 15-month term. The board cited expanding international operations as the reason.
Capillary Technologies India Other Announcement
Capillary Technologies appointed Deloitte Touche Tohmatsu India LLP as Internal Auditor, replacing Protiviti India. The change takes effect November 02, 2026.
Capillary Technologies India Results Update
Capillary announced Q2 FY27 revenue of ₹2,713.5 Mn (+51% YoY) and Adjusted EBITDA of ₹448.6 Mn (+103%). H1 FY27 revenue grew 47% with EBITDA up 116%.